402 related articles for article (PubMed ID: 1974554)
1. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
[No Abstract] [Full Text] [Related]
4. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
Adrian GS; Hutton JJ
J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
[TBL] [Abstract][Full Text] [Related]
6. Hot spot mutations in adenosine deaminase deficiency.
Hirschhorn R; Tzall S; Ellenbogen A
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6171-5. PubMed ID: 2166947
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
[TBL] [Abstract][Full Text] [Related]
8. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
Hirschhorn R; Ellenbogen A
Am J Hum Genet; 1986 Jan; 38(1):13-25. PubMed ID: 3946419
[TBL] [Abstract][Full Text] [Related]
10. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
Bonthron DT; Markham AF; Ginsburg D; Orkin SH
J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
[TBL] [Abstract][Full Text] [Related]
11. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
Cowan MJ; Smith W; Ammann AJ
Clin Immunol Immunopathol; 1989 Oct; 53(1):59-67. PubMed ID: 2569954
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
[TBL] [Abstract][Full Text] [Related]
14. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
Carson DA; Goldblum R; Keightley R; Seegmiller JE
Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
[No Abstract] [Full Text] [Related]
16. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
Uberti J; Peterson WD; Lightbody JJ; Johnson RM
J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
[TBL] [Abstract][Full Text] [Related]
17. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Cowan MJ; Shannon KM; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
[TBL] [Abstract][Full Text] [Related]
19. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
[TBL] [Abstract][Full Text] [Related]
20. Complete and partial adenosine deaminase deficiency. Relationship of immune function to metabolite concentrations, enzyme activity, and effects of therapy.
Hirschhorn R
Ann N Y Acad Sci; 1985; 451():20-5. PubMed ID: 3907453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
